Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
CTI BioPharma Corp.

CTI BioPharma Corp. (NASDAQ: CTIC) AI-Powered Stock Analysis

See how CTI BioPharma Corp. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.

CTIC●NASDAQ
HealthcareBiotechnology
$9.10
$0.005(0.06%)
U.S. Market opens in 37h 38m

CTI BioPharma Corp. (NASDAQ: CTIC) AI-Powered Stock Analysis

See how CTI BioPharma Corp. scores across key metrics like financial growth, valuation, and market position on the NASDAQ, using AI-driven evaluation.

Model Information

The AI Stock Analysis Model is provided for informational purposes only and should not be considered financial advice. We are continuously improving this model to increase accuracy and performance.Read our Full Disclaimer

CTI BioPharma Corp. (NASDAQ: CTIC) Stock Overall Grade

CTI BioPharma Corp.'s grade for its NASDAQ listing, based on a comprehensive AI analysis of financial metrics, growth potential, and market position.

Z

Grade Breakdown by Metric

See how each financial and market factor contributes to CTI BioPharma Corp.'s overall NASDAQ stock rating.

Forecast

B

Score

69/100

Financial Growth

C

Score

40/100

Fundamental Growth

C+

Score

50/100

Key Ratios

B+

Score

70/100

Sector Comparison

B

Score

65/100

Industry Comparison

C+

Score

50/100

S&P 500 Benchmark

A+

Score

98/100

Analyst Consensus

C+

Score

50/100

CTI BioPharma Corp. (NASDAQ: CTIC) AI-Powered Stock Analysis

On the NASDAQ, CTIC demonstrates Good performance with an overall Forecast Score of 69/100 (B), reflecting high confidence in its potential. Financial Growth (40/100, C) and Fundamental Growth (50/100, C+) highlight its stability, while Key Ratios (70/100, B+) and Sector Comparison (65/100, B) indicate solid positioning. Compared to broader benchmarks like the S&P 500 (98/100, A+), the NASDAQ-listed stock shows competitive strength. Analyst Consensus (50/100, C+) suggests Moderate divergence in outlook.

(NASDAQ: CTIC) Component Analysis Explained

Understand the key factors behind each CTI BioPharma Corp. (NASDAQ: CTIC) stock grade, including financials, comparisons, and forecasts.

Frequently Asked Questions